Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch

NCT06048536 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: MR-130A-01 Transdermal patch
DRUG: MR-130A-01 Transdermal patch
DRUG: MR-130A-01 Transdermal patch
DRUG: MR-130A-01 Transdermal patch

Sponsor

Mylan Pharmaceuticals Inc